Elsevier Launches Publishing Ethics Resource Kit

AMSTERDAM, March 4 /PRNewswire/ --

    - Online Resource to Support Journal Editors Handling Publishing Ethics 
Issues



    Elsevier, the world-leading publisher of scientific, technical and
medical information products and services, announced today the launch of its
Publishing Ethics Resource Kit (PERK) 
(http://www.elsevier.com/publishingethicskit).



    Launching PERK at the Elsevier Editors' Conference in Singapore, Mark
Seeley, Senior Vice President and General Legal Counsel, described PERK as
being "a single point of access for information and guidelines on publishing
ethics providing our Journal Editors with the support they need in dealing
with issues of publishing ethics."



    PERK is an online resource which contains links to Elsevier and
non-Elsevier policy and procedures documents, decision trees and flow charts
for dealing with different forms of publishing ethics abuse with the
recommended action that can be followed, as well as COPE (Committee On
Publication Ethics, http://www.publicationethics.org.uk/) charts for a second
opinion. It also contains examples of appropriate letters for various
situations and a large resource of useful information structured in the form
of Questions and Answers.



    As part of our commitment to the protection and enhancement of the
peer-review process, we have a responsibility to assist the scientific
community in all aspects of publishing ethics" says Martin Tanke, Managing
Director S&T Journal Publishing. "In the past months we have been the first
major scientific publisher to commit to full membership for all its
publications in COPE and we are one of six scientific publishers
participating in the CrossRef Association's pilot plagiarism software called
CrossCheck (http://www.elsevier.com/editors/plagdetect). By launching the
Publishing Ethics Resource Kit as well, we improve our efforts even more to
meet this responsibility".



About Elsevier

    Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. Working in partnership with the
global science and health communities, Elsevier's 7,000 employees in over 70
offices worldwide publish more than 2,000 journals and 1,900 new books per
year, in addition to offering a suite of innovative electronic products, such
as ScienceDirect (http://www.sciencedirect.com/), MD Consult 
(http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/),
bibliographic databases, and online reference works.



    Elsevier (http://www.elsevier.com/) is a global business headquartered in
Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of
Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading
publisher and information provider. Operating in the science and medical,
legal, education and business-to-business sectors, Reed Elsevier provides
high-quality and flexible information solutions to users, with increasing
emphasis on the Internet as a means of delivery. Reed Elsevier's ticker
symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and
ENL (New York Stock Exchange).



    
    Media Contacts:

    Federica Rosetta
    Elsevier
    [phone]
    [e-mail]